Veracyte MRD Assay
by Veracyte, Inc.
Categories
Data AnalysisCancer Detection
Description
AI-driven pipeline and assay for monitoring residual disease in cancer patients using whole genome sequencing.
Summary
The Veracyte MRD Assay combines whole genome sequencing with artificial intelligence to detect traces of cancer in blood samples. This approach characterizes the complete set of cancer mutations in a patient's tumor tissue and blood, developing an in silico patient-specific signature for accurate and robust tracking of tumor progression. It aims to provide faster results with less blood required, facilitating earlier detection and potentially better outcomes for patients.
Use Cases
- Detecting residual disease in patients with muscle invasive bladder cancer.
- Monitoring tumor progression and treatment efficacy through non-invasive blood tests.
Platforms
Web
Regulatory Status
not a medical deviceAPI Available
NoAdded to Directory
6/27/2025Target Customer
Clinician